| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Nissenson Allen serves as a Director at RMTI and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $11K at current prices.
The biggest single holding is ELTX (~$11K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 9,383 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | ELTX Elicio Therapeutics, Inc. | Director | Buy | 9,383 | $1.16 | $10,925.02 | New | -20.3% | -38.3% |